Rosenblatt downgrades Synaptics to Neutral, lowers target to $160
Rosenblatt analyst Kevin Cassidy downgraded Synaptics from Buy to Neutral, reducing the price target from $180 to $160. The rating change suggests a shift in investment perspective and advises investors to hold current positions.
*this image is generated using AI for illustrative purposes only.
Rosenblatt analyst Kevin Cassidy has downgraded Synaptics from Buy to Neutral, adjusting the firm's outlook on the stock. The rating revision signals a shift in the investment perspective regarding the company's near-term performance. Concurrently, the price target was lowered from $180 to $160, indicating a revised valuation expectation alongside the more cautious rating.
The downgrade moves Synaptics out of the Buy category, suggesting that the previous upside potential may have diminished or that risks have increased. The Neutral rating indicates that investors should maintain their current positions rather than accumulate new shares.
Analyst Action
The following table details the rating change:
| Firm | Analyst | Previous Rating | New Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|---|
| Rosenblatt | Kevin Cassidy | Buy | Neutral | $180 | $160 |
The decision by Rosenblatt impacts market sentiment surrounding Synaptics, which is listed on the NASDAQ under the ticker symbol SYNA.
What specific factors led to the diminished upside potential for Synaptics?
How might this downgrade affect Synaptics' stock performance in the near term?
Are there broader market conditions influencing this cautious outlook?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
